Colorectal Cancer Trial, Recruiting NCT05713903 Sponsor: Larissa University Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05713903
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cancer in the right side of the colon (specifically the cecum, ascending colon, or hepatic flexure), confirmed by a tissue sample test
  • People whose surgery will follow a specific surgical technique called Complete Mesocolic Excision (CME)
  • People aged 18 to 90 years old
  • People whose overall health and fitness for surgery falls within an acceptable range, as rated by a standard anaesthesia risk scale (ASA score of III or below)
  • People whose cancer has not grown too deeply into or through the bowel wall (tumour stage T3 or lower)
  • People whose surgery is planned in advance, not done as an emergency

Who may not be able to join:

  • People needing emergency surgery due to bleeding, a bowel perforation, or a blockage
  • People whose cancer has grown through the outer layer of the bowel wall (T4 stage)
  • People whose cancer has spread to other parts of the body (Stage IV)
  • People whose general health makes the risk of anaesthesia too high (ASA score of IV or above)
  • People who have previously had open abdominal surgery
  • People with a Body Mass Index (BMI) over 35
  • People with an active serious infection or blood poisoning at the time of the trial
  • People with a physical or mental health condition that has not been treated or managed
  • People who are pregnant or breastfeeding
  • People who are unlikely to be able to follow the trial's required procedures and schedule
  • People who have not given signed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Konstantinos Perivoliotis, MD, University Hospital of Larissa

Phone: 2413501000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Larissa University Hospital
Registry
ClinicalTrials.gov
Start date
6 February 2023
Est. completion
10 January 2027

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Mesocolic Resection Plane

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov